Our Company

Oncophenomics is a personalized medicine startup based out of Hyderabad, India. We are developing innovative products in the “theranostics” (therapy + diagnostics) space.

Our mission

We are on a mission to prevent cancer recurrence. Cancer spreads from primary tumor in the form of circulating tumor cells (CTCs). We are targeting these CTCs to study their sensitivity and resistance to chemotherapy drugs.

Our Vision

We want to improve cancer treatment outcomes by promoting personalized medicine approach. Liquid biopsy is a powerful tool for oncologists to customize the treatment plan.

Our technology

Our liquid biopsy platform is an innovative microfluidics lab-on-a-chip technology that is used for detection and capture of viable circulating tumor cells from a simple blood sample of cancer patients – being non invasive it can be repeated as many as required for treatment monitoring and evaluating clinical outcomes


Using microfludics technology we can miniaturize any in vitro diagnostics assay on a glass slide (chip) that saves time and ability to detect biological parameters even at nanoscales


Using 3D Bioprinting technology we can create artificial tissue slices (mimicking the actual organs) in vitro to simulate the tumor microenvironment and study the effect of drugs on patient derived primary cancer cells using this platform

Cancer Genomics

Next Generation Sequencing has opened up new possibilities to study the mutational profiling of tumor tissues and circulating tumor cells